![](/images/general/no_picture/200_user.png)
Nashaat T Nashed
Examiner (ID: 13355, Phone: (571)272-0934 , Office: P/1656 )
Most Active Art Unit | 1656 |
Art Unit(s) | 1621, 1656, 1814, 1652 |
Total Applications | 1418 |
Issued Applications | 902 |
Pending Applications | 112 |
Abandoned Applications | 404 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16484017
[patent_doc_number] => 20200377618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => VL ANTIGEN BINDING PROTEINS EXHIBITING DISTINCT BINDING CHARACTERISTICS
[patent_app_type] => utility
[patent_app_number] => 16/996302
[patent_app_country] => US
[patent_app_date] => 2020-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31729
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16996302
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/996302 | VL ANTIGEN BINDING PROTEINS EXHIBITING DISTINCT BINDING CHARACTERISTICS | Aug 17, 2020 | Pending |
Array
(
[id] => 16481556
[patent_doc_number] => 20200375156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => GENETIC MARKERS AND USES THEREFOR
[patent_app_type] => utility
[patent_app_number] => 16/987086
[patent_app_country] => US
[patent_app_date] => 2020-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34924
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 248
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16987086
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/987086 | GENETIC MARKERS AND USES THEREFOR | Aug 5, 2020 | Pending |
Array
(
[id] => 17428772
[patent_doc_number] => 20220056480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => MODIFIED ORTHOPOXVIRUS VECTORS
[patent_app_type] => utility
[patent_app_number] => 17/415575
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 168945
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -178
[patent_words_short_claim] => 1
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17415575
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/415575 | MODIFIED ORTHOPOXVIRUS VECTORS | Dec 19, 2019 | Pending |
Array
(
[id] => 17595722
[patent_doc_number] => 20220145296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/418498
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58155
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17418498
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/418498 | POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE | Dec 19, 2019 | Pending |
Array
(
[id] => 17460641
[patent_doc_number] => 20220073946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => VIRUS-LIKE PARTICLES OF CMV MODIFIED BY FUSION
[patent_app_type] => utility
[patent_app_number] => 17/414730
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42557
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17414730
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/414730 | VIRUS-LIKE PARTICLES OF CMV MODIFIED BY FUSION | Dec 19, 2019 | Pending |
Array
(
[id] => 17867395
[patent_doc_number] => 20220290131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => HYBRID PROMOTERS AND THEIR USES IN THERAPY, NOTABLY FOR TREATING TYPE II COLLAGENOPATHIES
[patent_app_type] => utility
[patent_app_number] => 17/415440
[patent_app_country] => US
[patent_app_date] => 2019-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13631
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17415440
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/415440 | HYBRID PROMOTERS AND THEIR USES IN THERAPY, NOTABLY FOR TREATING TYPE II COLLAGENOPATHIES | Dec 17, 2019 | Pending |
Array
(
[id] => 17357064
[patent_doc_number] => 20220017860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => Hepatocyte Expansion Methods
[patent_app_type] => utility
[patent_app_number] => 17/296049
[patent_app_country] => US
[patent_app_date] => 2019-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22464
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17296049
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/296049 | Hepatocyte Expansion Methods | Nov 25, 2019 | Pending |
Array
(
[id] => 17480659
[patent_doc_number] => 20220088163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => HYBRID IMMOLATIVE CELL-PENETRATING COMPLEXES FOR NUCLEIC ACID DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/292370
[patent_app_country] => US
[patent_app_date] => 2019-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74003
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17292370
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/292370 | HYBRID IMMOLATIVE CELL-PENETRATING COMPLEXES FOR NUCLEIC ACID DELIVERY | Nov 10, 2019 | Pending |
Array
(
[id] => 17299852
[patent_doc_number] => 20210395691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => MEANS AND METHODS OF PREVENTING OR REVERSING AGING
[patent_app_type] => utility
[patent_app_number] => 17/309208
[patent_app_country] => US
[patent_app_date] => 2019-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10500
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17309208
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/309208 | MEANS AND METHODS OF PREVENTING OR REVERSING AGING | Nov 7, 2019 | Pending |
Array
(
[id] => 17385928
[patent_doc_number] => 20220033780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => METHOD FOR PREPARING INTESTINAL ORGANOID DERIVED FROM PLURIPOTENT STEM CELL
[patent_app_type] => utility
[patent_app_number] => 17/290446
[patent_app_country] => US
[patent_app_date] => 2019-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25810
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17290446
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/290446 | METHOD FOR PREPARING INTESTINAL ORGANOID DERIVED FROM PLURIPOTENT STEM CELL | Oct 30, 2019 | Pending |
Array
(
[id] => 17274777
[patent_doc_number] => 20210380975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => RNA-GUIDED TRANSCRIPTIONAL REGULATION AND METHODS OF USING THE SAME FOR THE TREATMENT OF BACK PAIN
[patent_app_type] => utility
[patent_app_number] => 17/284908
[patent_app_country] => US
[patent_app_date] => 2019-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32785
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17284908
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/284908 | RNA-GUIDED TRANSCRIPTIONAL REGULATION AND METHODS OF USING THE SAME FOR THE TREATMENT OF BACK PAIN | Oct 17, 2019 | Pending |
Array
(
[id] => 17214822
[patent_doc_number] => 20210348159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => COMPOSITIONS AND METHODS FOR DELIVERING TRANSGENES
[patent_app_type] => utility
[patent_app_number] => 17/286276
[patent_app_country] => US
[patent_app_date] => 2019-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63937
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -111
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17286276
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/286276 | COMPOSITIONS AND METHODS FOR DELIVERING TRANSGENES | Oct 16, 2019 | Pending |
Array
(
[id] => 17274808
[patent_doc_number] => 20210381006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => METHOD FOR ACTIVATION/PROLIFERATION OF T CELLS
[patent_app_type] => utility
[patent_app_number] => 17/286334
[patent_app_country] => US
[patent_app_date] => 2019-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19202
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17286334
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/286334 | METHOD FOR ACTIVATION/PROLIFERATION OF T CELLS | Oct 16, 2019 | Pending |
Array
(
[id] => 18109910
[patent_doc_number] => 20230002790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => POLY(Beta-AMINO ESTER) NANOPARTICLES FOR THE NON-VIRAL DELIVERY OF PLASMID DNA FOR GENE EDITING AND RETINAL GENE THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/282939
[patent_app_country] => US
[patent_app_date] => 2019-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75365
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17282939
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/282939 | POLY(Beta-AMINO ESTER) NANOPARTICLES FOR THE NON-VIRAL DELIVERY OF PLASMID DNA FOR GENE EDITING AND RETINAL GENE THERAPY | Oct 9, 2019 | Pending |
Array
(
[id] => 17343940
[patent_doc_number] => 20220010271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => METHOD FOR PRODUCING BRAIN ORGANOIDS
[patent_app_type] => utility
[patent_app_number] => 17/293355
[patent_app_country] => US
[patent_app_date] => 2019-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13275
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17293355
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/293355 | METHOD FOR PRODUCING BRAIN ORGANOIDS | Oct 9, 2019 | Pending |
Array
(
[id] => 17227213
[patent_doc_number] => 20210353769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => SURFACE MODIFIED EXTRACELLULAR VESICLES
[patent_app_type] => utility
[patent_app_number] => 17/278280
[patent_app_country] => US
[patent_app_date] => 2019-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23899
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17278280
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/278280 | SURFACE MODIFIED EXTRACELLULAR VESICLES | Sep 19, 2019 | Pending |
Array
(
[id] => 17444107
[patent_doc_number] => 20220064612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => PaCas9 nuclease
[patent_app_type] => utility
[patent_app_number] => 17/276016
[patent_app_country] => US
[patent_app_date] => 2019-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4749
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17276016
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/276016 | PaCas9 nuclease | Sep 12, 2019 | Pending |
Array
(
[id] => 17563473
[patent_doc_number] => 20220127622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => Compositions and Methods for Improving Base Editing
[patent_app_type] => utility
[patent_app_number] => 17/273071
[patent_app_country] => US
[patent_app_date] => 2019-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50548
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17273071
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/273071 | Compositions and Methods for Improving Base Editing | Sep 6, 2019 | Pending |
Array
(
[id] => 17154887
[patent_doc_number] => 20210315938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => Methods and Compositions for Retinal Neuron Generation in Carrier-Free 3D Sphere Suspension Culture
[patent_app_type] => utility
[patent_app_number] => 17/273747
[patent_app_country] => US
[patent_app_date] => 2019-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19276
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17273747
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/273747 | Methods and Compositions for Retinal Neuron Generation in Carrier-Free 3D Sphere Suspension Culture | Sep 5, 2019 | Pending |
Array
(
[id] => 17200403
[patent_doc_number] => 20210340498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => MEDIUM FOR DIRECT DIFFERENTIATION OF PLURIPOTENT STEM CELL-DERIVED MESENCHYMAL STEM CELL, METHOD FOR PREPARING MESENCHYMAL STEM CELL BY USING SAME, AND MESENCHYMAL STEM CELL PREPARED THEREBY
[patent_app_type] => utility
[patent_app_number] => 17/274029
[patent_app_country] => US
[patent_app_date] => 2019-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8193
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17274029
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/274029 | MEDIUM FOR DIRECT DIFFERENTIATION OF PLURIPOTENT STEM CELL-DERIVED MESENCHYMAL STEM CELL, METHOD FOR PREPARING MESENCHYMAL STEM CELL BY USING SAME, AND MESENCHYMAL STEM CELL PREPARED THEREBY | Sep 5, 2019 | Pending |